FORA · As filed with the SEC
Forian cash flow statement, by fiscal year
The statement as Forian presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
| Net loss | (2,874,042) | (3,771,070) | 11,106,687 | (25,971,971) |
| Less: Income from discontinued operations | — | 0 | 9,373,257 | — |
| (Loss) Income from continuing operations | — | (3,771,070) | 1,733,430 | — |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
| Depreciation and amortization | 207,722 | 63,389 | 74,438 | 2,892,543 |
| Amortization on right of use asset | 23,423 | 21,980 | 21,896 | 263,232 |
| Gain on sale of businesses, net | — | — | — | (32,931) |
| Gain on bargain purchase | 0 | (1,204,830) | — | — |
| Amortization of debt issuance costs | 3,555 | 5,333 | 5,333 | 5,332 |
| Amortization of discount - proceeds from sale of discontinued operations | 0 | (20,712) | (389,288) | — |
| Interest accrued on convertible notes | 138,796 | 703,600 | 829,452 | 840,767 |
| Realized and unrealized gain on marketable securities | — | — | — | (265,443) |
| Accretion of discounts on marketable securities | (1,098,372) | (2,321,188) | (1,876,085) | — |
| Gain on sale of investment | 0 | (80,694) | (5,805,858) | — |
| Gain on debt redemption | 0 | (283,059) | (111,151) | — |
| Provision for credit losses | 132,025 | 225,000 | — | 250,239 |
| Stock-based compensation expense | 3,276,379 | 6,528,397 | 6,573,969 | 13,310,588 |
| Change in fair value of warrant liability | 0 | (563) | (3,984) | (364,687) |
| Foreign currency related (gains) losses, net | — | — | — | (47,226) |
| Issuance of warrants in connection with transaction expenses | — | — | — | 0 |
| Change in operating assets and liabilities: | ||||
| Accounts receivable | (1,721,398) | (856,719) | (763,903) | (896,677) |
| Contract assets | 65,464 | 64,097 | 1,126,245 | (1,196,067) |
| Prepaid expenses | 120,324 | 75,933 | (241,447) | (41,977) |
| Lease liabilities | (23,423) | (33,381) | (21,896) | (256,581) |
| Deposits and other assets | 679,628 | 963,710 | (1,520,022) | 527,023 |
| Accounts payable | 2,850,857 | 821,075 | (154,521) | (529,075) |
| Accrued expenses | 842,028 | (331,990) | 479,021 | 634,909 |
| Deferred revenues | 763,507 | 203,118 | (167,736) | 2,102,437 |
| Other liabilities | (500,000) | (488,599) | 1,000,000 | — |
| Net cash provided by operating activities - continuing operations | — | 282,827 | 787,893 | — |
| Net cash used in operating activities - discontinued operations | — | 0 | (59,075) | — |
| Net cash provided by operating activities | 2,886,473 | 282,827 | 728,818 | (8,775,565) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||
| Additions to property and equipment | — | 0 | (75,493) | (1,711,455) |
| Purchase of marketable securities | (83,174,769) | (152,354,967) | (144,077,731) | (55,819,346) |
| Sale and maturity of marketable securities | 96,118,000 | 166,480,656 | 121,053,714 | 51,087,663 |
| Net cash from sale of business | — | — | — | (17,907) |
| Proceeds from sale of investment | 0 | 80,694 | 5,805,858 | — |
| Cash from acquisition | 0 | 1,415,696 | — | 0 |
| Net cash from sale of discontinued operations | 0 | 1,666,666 | 24,413,595 | — |
| Net cash provided by investing activities - continuing operations | — | 17,288,745 | 7,119,943 | — |
| Net cash used in investing activities - discontinued operations | — | — | 0 | — |
| Net cash provided by investing activities | 12,943,231 | 17,288,745 | 7,119,943 | (6,461,045) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||
| Proceeds from exercise of MOR Class B options | — | — | — | 0 |
| Payments on notes payable and financing arrangements | — | — | 0 | (13,122) |
| Tax payments related to shares withheld for vested restricted stock units | (263,661) | (132,591) | (191,465) | (87,406) |
| Proceeds from exercise of common stock options | — | — | — | 0 |
| Proceeds from sale of common stock | — | — | — | 0 |
| Proceeds from the issuance of convertible notes payable | — | — | — | 0 |
| Stock repurchase | — | (292,900) | (3,450,053) | — |
| Repurchase of common stock | (412,944) | — | — | — |
| Cash used to redeem convertible notes | (6,840,000) | (18,598,406) | (960,000) | — |
| Net cash used in financing activities - continuing operations | — | (19,023,897) | (4,601,518) | — |
| Net cash used in financing activities | (7,516,605) | (19,023,897) | (4,601,518) | (100,528) |
| Effect of foreign exchange rate changes on cash | — | — | — | (6,769) |
| Net change in cash and cash equivalents | 8,313,099 | (1,452,325) | 3,247,243 | (15,343,907) |
| Cash and cash equivalents, beginning of year | 4,590,661 | 6,042,986 | 2,795,743 | 18,663,805 |
| Cash and cash equivalents, end of year | 12,903,760 | 4,590,661 | 6,042,986 | 3,319,898 |
| Supplemental disclosure of cash flow information: | ||||
| Cash paid (received) for taxes | 220,764 | (1,629,767) | 4,066,385 | 18,444 |
| Non-cash consideration for Helix acquisition | — | — | — | 0 |
| Cash paid for interest | 840,000 | — | — | 0 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.